Nasdaq Approves Listing of Canary Capital Staked Injective ETF
November 5, 2026
Nasdaq has approved listing rules for Canary Capital's Staked Injective ETF (INJC). The fund plans to stake at least 90% of its INJ tokens and carries a 1.10% annual fee.
Read more
Injective (INJ) Surges 27% Following 21Shares Institutional Staking Fund Proposal
October 18, 2026
Injective (INJ) jumped 27% in 24 hours, outpacing NEAR, Sei, and Cosmos Hub following a new 21Shares fund proposal that includes direct token holdings and discretionary staking.
Read more
Injective Activates Fixed Gas Costs to Enhance On-Chain Trading Experience
October 18, 2026
Injective has activated fixed gas costs for core exchange transactions, eliminating the need for pre-trade simulations and offering deterministic fees for traders and developers.
Read more